Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study
暂无分享,去创建一个
Hongbing Shen | Jianfeng Xu | Zhibin Hu | Ci Song | J. Dai | X. Zhai | F. Zhu | Li Liu | Jianguo Chen | Yue Jiang | D. Jiang | T. Jin | Yefei Zhu | Jibin Liu | J. Wen | J. An | N. Qin | Jie Jiang | Chao Chen | Jiaping Chen | Yao-shun Liu | T. Geng | Long Yu | Liguo Zhu | Linlin Yang | Cheng Liang | Shi-guang Ma
[1] G. Cao,et al. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[2] R. Ni,et al. Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.
[3] J. Jang,et al. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma , 2014, Journal of viral hepatitis.
[4] Hongbing Shen,et al. New loci associated with chronic hepatitis B virus infection in Han Chinese , 2013, Nature Genetics.
[5] G. Cao,et al. HLA-DP Polymorphisms Affect the Outcomes of Chronic Hepatitis B Virus Infections, Possibly through Interacting with Viral Mutations , 2013, Journal of Virology.
[6] Sheng-Nan Lu,et al. Role of Viral Genotypes and Hepatitis B Viral Mutants in the Risk of Hepatocellular Carcinoma Associated with Hepatitis B and C Dual Infection , 2013, Intervirology.
[7] G. Cao,et al. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma , 2013, Hepatology.
[8] S. Friedman,et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. , 2013, Gastroenterology.
[9] Qiang Ding,et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma , 2012, Nature Genetics.
[10] Hongbing Shen,et al. GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers , 2012, PLoS genetics.
[11] Hongbing Shen,et al. Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development , 2012, Hepatology.
[12] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[13] Y. Kamatani,et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. , 2011, Human molecular genetics.
[14] G. Cao,et al. A matched case–control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma , 2011, Journal of medical virology.
[15] G. Cao,et al. Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma , 2011, The American Journal of Gastroenterology.
[16] Jianren Gu,et al. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. , 2011, Carcinogenesis.
[17] V. Mazzaferro,et al. Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis , 2010, PLoS pathogens.
[18] G. Cao,et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma , 2010, Journal of Gastroenterology.
[19] G. Cao,et al. Distribution and Hepatocellular Carcinoma–Related Viral Properties of Hepatitis B Virus Genotypes in Mainland China: A Community-Based Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[20] G. Cao. Clinical relevance and public health significance of hepatitis B virus genomic variations. , 2009, World journal of gastroenterology.
[21] B. McMahon,et al. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B , 2009, Hepatology international.
[22] Y. Kamatani,et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.
[23] M. Yuen,et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. , 2009, Journal of hepatology.
[24] G. Qian,et al. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. , 2008, Journal of hepatology.
[25] P. Zhang,et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. , 2008, Carcinogenesis.
[26] G. Cao,et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China , 2008, Gut.
[27] Chien-Jen Chen,et al. Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.
[28] V. Wong,et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Chien-Jen Chen,et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. , 2008, Carcinogenesis.
[30] Shu Zheng,et al. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma , 2007, Hepatology.
[31] F. Zoulim,et al. Hepatitis B virus genetic variability and evolution. , 2007, Virus research.
[32] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[33] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[34] P. Coursaget,et al. Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes , 2004, Intervirology.
[35] M. Buti. [Hepatitis B virus genotypes]. , 2003, Gastroenterologia y hepatologia.
[36] A. Lok,et al. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. , 2002, Hepatology.
[37] Chien-Jen Chen,et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.
[38] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[39] C. Dauguet,et al. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection , 1991, Journal of virology.
[40] T. Gojobori,et al. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[41] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.